
Zevra Therapeutics Inc (ZVRA) with a beta value of 1.56 appears to be a promising investment opportunity.
On Friday, Zevra Therapeutics Inc (NASDAQ: ZVRA) was 5.96% up from the session before settling in for the closing price of $8.9. A 52-week range